Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab

Pembrolizumab is an immune checkpoint inhibitor used in many cancer types, including genitourinary cancers. Although immunotherapies have dramatically changed the landscape of cancer treatment by providing an alternative to traditional chemotherapy, they have been associated with significant immune-...

Descripción completa

Detalles Bibliográficos
Autores principales: McCormick, Benjamin Joseph, Zieman, Daniel, West-Santos, Cassidy, Phillips, Michael B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Reports: Adverse drug reactions and complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314548/
https://www.ncbi.nlm.nih.gov/pubmed/37339826
http://dx.doi.org/10.1136/bcr-2023-254692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314548/
https://www.ncbi.nlm.nih.gov/pubmed/37339826
http://dx.doi.org/10.1136/bcr-2023-254692

Ejemplares similares